Overexpression of the key metabolic protein Carnitine Palmitoyl Transferase 1A (CPT1A) in equine sarcoid.
Authors: Martano Manuela, Power Karen, Cuccaro Bianca, Razzuoli Elisabetta, Maiolino Paola, Restucci Brunella
Journal: Journal of equine veterinary science
Summary
# Editorial Summary Equine sarcoids represent a significant clinical challenge as the most prevalent fibroblastic skin neoplasm in horses, with tumour fibroblasts characteristically producing excessive extracellular matrix under hypoxic conditions that favour reliance on alternative metabolic pathways. This 2024 research by Martano and colleagues investigated whether CPT1A—a critical enzyme that shuttles fatty acids into mitochondria for β-oxidation—is upregulated in sarcoid tissue compared with normal skin, examining 25 sarcoid samples and 5 control tissues using immunohistochemistry with Western Blotting validation. The findings revealed markedly elevated CPT1A expression in 60% of sarcoid samples, predominantly localised to the cytoplasm of neoplastic fibroblasts, with unexpected nuclear localisation also observed; by contrast, normal skin showed only weak, basal epidermal and sparse dermal fibroblast staining. CPT1A's cytoplasmic abundance indicates active engagement in the metabolic reprogramming required to sustain sarcoid growth under hypoxia, whilst nuclear presence suggests involvement in proliferative signalling beyond its canonical role in fatty acid oxidation. For practitioners, this work provides molecular evidence that sarcoid cells exploit lipid metabolism as a growth strategy, potentially opening therapeutic avenues targeting the carnitine shuttle system or downstream energy pathways, and warrants investigation of whether metabolic interventions could complement current surgical and immunological treatment approaches.
Read the full abstract on PubMed
Practical Takeaways
- •CPT1A overexpression in sarcoids reveals a metabolic adaptation strategy allowing tumor cells to thrive in hypoxic conditions—this may inform future targeted treatment approaches beyond current surgical and immunological interventions
- •Understanding that sarcoid fibroblasts preferentially use fatty acid oxidation for energy could eventually lead to metabolic-based therapies, though this research is still at the basic science stage
- •This molecular finding does not change current diagnostic or management protocols for sarcoids but strengthens the rationale for ongoing research into metabolic vulnerabilities of equine tumors
Key Findings
- •CPT1A was overexpressed in 60% of equine sarcoid samples with strong cytoplasmic and nuclear staining, compared to weak expression limited to basal epidermis in normal skin
- •Cytoplasmic CPT1A expression in sarcoid fibroblasts indicates active involvement in metabolic reprogramming and fatty acid oxidation
- •Nuclear CPT1A expression suggests additional role in regulating neoplastic cell proliferation beyond fatty acid metabolism